
Sign up to save your podcasts
Or


Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
By JAMA Network3.8
1111 ratings
Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial

321 Listeners

504 Listeners

39 Listeners

163 Listeners

59 Listeners

113,121 Listeners

38 Listeners

56,944 Listeners

21 Listeners

16 Listeners

8 Listeners

17 Listeners

19 Listeners

5 Listeners

6 Listeners

46 Listeners

31 Listeners

9 Listeners

94 Listeners

14 Listeners

5 Listeners

5 Listeners

106 Listeners

18 Listeners

15,506 Listeners

2 Listeners

1,209 Listeners